Related Experiment Video
Updated: Sep 14, 2025
![Assessment of Gastric Emptying in Non-obese Diabetic Mice Using a [13C]-octanoic Acid Breath Test](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F50301.jpg&w=3840&q=50)
Assessment of Gastric Emptying in Non-obese Diabetic Mice Using a [13C]-octanoic Acid Breath Test
Published on: March 23, 2013
Proposed Algorithm for the Diagnosis and Management of Diabetic Gastroparesis in the Indian Clinical Setting
Mohan V G Prasad1, Nitesh Pratap2, Showkat Zargar3
1VGM Hospital, Singanallur, Coimbatore, Tamil Nadu, India.
Abstract:
Diabetic gastroparesis (DGP) is a microvascular complication of diabetes, characterised by delayed gastric emptying and cardinal symptoms such as nausea, vomiting, early satiety, post-meal discomfort, bloating, and appetite loss. Diagnosis relies on identifying these symptoms and excluding obstructions. India-specific DGP management algorithm was developed by 50 expert gastroenterologists across India. It offers a systematic approach tailored to Indian clinical settings, emphasising a comprehensive evaluation encompassing medical history, clinical examination, and laboratory investigations for diagnosing DGP. The management strategy involves glycemic control, dietary adjustments, prokinetics with antiemetics, and stepwise treatment modification if initial approaches prove ineffective. Additionally, the algorithm underscores the significance of endoscopic evaluation and gastric emptying studies in DGP diagnosis, as well as the use of prokinetics, antiemetics, and neuromodulators in treatment. Notably, the experts favoured itopride as the preferred and relatively safer prokinetic for treating DGP and its varied clinical presentations.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

